BSD Medical Reports Growing Interest in MicroThermX® Microwave Ablation System at CIRSE – the World's Largest Conference on Interventional Radiology Products

Published: Sep 27, 2012

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that physicians at the CIRSE conference reported microwave ablation treatment has the potential to become a primary first-line treatment option for certain tumors because of its efficacy, safety, ease of use, and low cost. CIRSE (Cardiovascular and Interventional Radiological Society of Europe), which was held in Lisbon, Portugal, September 15-19, 2012, is the world's largest and most prestigious conference in the field of minimally invasive image-guided therapies. Over 6,000 medical professionals from 80 countries attended CIRSE, reflecting the global impact of the rapidly expanding field of interventional radiology. The soft tissue ablation world market potential is estimated to exceed $2.3 billion.

Back to news